SCHEMBL3500987

SCHEMBL3500987

Nc1nnc(S(N)(=O)=O)s1.[NaH]

nearest known ligand 0.95

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 18/20 0.95
CA1 P00915 16/20 0.95
CA9 Q16790 10/20 0.95
CA4 P22748 7/20 0.95
CA12 O43570 5/20 0.95
CA7 P43166 5/20 0.95
CA6 P23280 4/20 0.95
CA5A P35218 4/20 0.95
CA5B Q9Y2D0 4/20 0.95
CA14 Q9ULX7 3/20 0.95
CA13 Q8N1Q1 2/20 0.95
CA3 P07451 3/20 0.44
MEN1 O00255 1/20 0.44
CA11 O75493 1/20 0.44
THRB P10828 1/20 0.44
BLM P54132 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282413 0.98 CA2 (1.00) CA2CA1CA9CA4CA12
Hydrochloric Acid SCHEMBL2987404 0.95 CA2 (0.95) CA2CA1CA9CA4CA12
SCHEMBL9796194 0.82 CA2 (0.71) CA2CA1CA9CA4CA12
SCHEMBL6507990 0.76 CA2 (0.64) CA2CA1CA9CA4CA12
SCHEMBL11169964 0.76 CA2 (0.64) CA2CA1CA9CA4CA12
SCHEMBL2648743 0.76 CA2 (0.64) CA2CA1CA9CA4CA12
SCHEMBL9860007 0.73 CA2 (0.59) CA2CA1CA9CA4CA12
SCHEMBL21267685 0.73 CA2 (0.59) CA2CA1CA9CA4CA12
SCHEMBL22592813 0.71 CA2 (0.58) CA2CA1CA9CA4CA12
SCHEMBL10711085 0.71 CA2 (0.58) CA2CA1CA9CA4CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 US disclosed